Cochrane
Systematic review
Feb 2019
Patients and professionals
A Cochrane review of 18 trials that tested cutting down or cutting out foods thought to provoke IBD symptoms. The authors found the evidence too weak to say whether any of these diets help bring on or keep remission, and called for better trials. This summary dates from 2019.
Topics
Diet and nutrition
Research
Jargon explained
remission
exclusion diet
randomised controlled trial
New England Journal of Medicine
Study
Apr 2010
Patients and professionals
A landmark trial of 508 adults with moderate to severe Crohn's who had never had immunosuppressants or biologics. Infliximab and azathioprine together worked best: about 57% were in remission without steroids at 26 weeks, against 44% on infliximab alone and 30% on azathioprine alone. This is why many people starting infliximab are offered a second 'helper' drug alongside it.
Topics
Biologics and newer medicines
Immunosuppressants
Research
Jargon explained
combination therapy
steroid-free remission
mucosal healing
randomised controlled trial
The Lancet Gastroenterology & Hepatology
Study
May 2024
Patients and professionals
A large UK-led trial of 386 newly diagnosed adults. Starting straight away with infliximab plus an immunosuppressant ('top-down') kept 79% in remission without steroids or surgery for a year, compared with 15% using the usual 'step-up' approach of trying milder drugs first. There were also fewer flares, serious side effects and operations. A blood test meant to predict who needed strong treatment did not help. Free to read in full.
Topics
Biologics and newer medicines
Research
About Crohn's disease
Jargon explained
top-down treatment
step-up treatment
biomarker
steroid-free remission
top-down
step-up
immunomodulator
randomised controlled trial
Cochrane
Systematic review
Feb 2019
Patients and professionals
Reviewed trials of special diets (such as low-sugar, low-red-meat or exclusion diets) for Crohn's and colitis. The effects were uncertain and no firm conclusions could be drawn. The authors say experts need to agree what the diets should contain and more trials are needed.
Topics
Diet and nutrition
Jargon explained
dietary intervention
randomised controlled trial
Gastroenterology
Study
Aug 2019
Patients and professionals
A trial in 78 children with mild to moderate Crohn's. The Crohn's Disease Exclusion Diet (CDED) plus half their calories from a special drink was much easier to stick to than a liquid-only diet (EEN). Both worked well at 6 weeks, but by 12 weeks more children on CDED were still in remission (76% against 45%). It made CDED a recognised option for children.
Topics
Diet and nutrition
Children and young people
Jargon explained
Crohn's disease exclusion diet
partial enteral nutrition
exclusive enteral nutrition
microbiome
NHS
Web page
Dec 2022
For patients
The NHS explains what a clinical trial is and how to find one. It suggests asking your doctor or a patient organisation, and points to the Be Part of Research website, where you can search UK studies and contact researchers.
Topics
Research
Jargon explained
clinical trial
randomised
The Lancet
Study
Dec 2017
Patients and professionals
CALM compared deciding treatment on symptoms alone with 'tight control', where treatment was stepped up if blood or poo tests (CRP and faecal calprotectin) showed inflammation even when people felt fine. After 48 weeks, 46% in the tight control group had a healed bowel lining compared with 30% in the symptom-only group. It is a cornerstone of the 'treat to target' approach.
Topics
Monitoring
Biologics and newer medicines
Research
Jargon explained
tight control
faecal calprotectin
CRP
mucosal healing
treat to target
US National Library of Medicine
Tool
Patients and professionals
The largest worldwide database of clinical studies, run by the US government. It includes many trials running at UK hospitals, often drug-company trials of new Crohn's medicines. Each record lists the study's aim, who can join and where.
Topics
Research
Jargon explained
clinical trial
eligibility criteria
trial registry
NCT number
Crohn's & Colitis UK
Web page
Jul 2026
For patients
Explains how new IBD medicines move from lab testing through clinical trials to licensing, and describes medicines currently in late-stage testing.
Topics
Research
Medicines
Jargon explained
clinical trial
licensing
phase 3
The Lancet
Study
May 2002
Patients and professionals
This trial asked whether people who improve after a first dose of infliximab should keep having it. Those given regular doses every 8 weeks were more likely to be in remission at 30 and 54 weeks, more likely to come off steroids, and stayed well for longer than those who stopped. Serious infections were no more common. It set the pattern of regular, ongoing infliximab treatment.
Topics
Biologics and newer medicines
Research
Jargon explained
maintenance therapy
remission
placebo
The Lancet
Study
Feb 2015
For professionals
A trial of how to stop Crohn's returning after bowel surgery. Treating people according to their risk, checking with a colonoscopy at six months and stepping up treatment if the disease had come back worked better than standard drug treatment alone. It also showed that even low-risk patients need monitoring.
Topics
Surgery
Monitoring
Research
Jargon explained
post-operative recurrence
colonoscopy
step-up
resection
NIHR
Tool
For patients
The NHS research service's search tool for finding health studies to take part in across the UK. Searching for Crohn's disease lists studies currently recruiting, with who can join and where. A good first stop if you want to volunteer for a trial.
Topics
Research
Jargon explained
clinical trial
recruiting